Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 5/20 | 0.44 |
| ▸ | CA1 | P00915 | 4/20 | 0.44 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 2/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.41 |
| ▸ | ATM | Q13315 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.40 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.40 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.40 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.40 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.40 |
| ▸ | SLC15A1 | P46059 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | FAAH | O00519 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL224692 | 0.88 | ALOX15 (0.46) | CA2CA1ALOX15TSHRCYP3A4 | |
| SCHEMBL28656944 | 0.84 | CHRNB2 (0.40) | ALOX15TSHRCHRNB2CHRNB4CHRNA3 | |
| SCHEMBL28656945 | 0.84 | CHRNB2 (0.40) | ALOX15TSHRCHRNB2CHRNB4CHRNA3 | |
| SCHEMBL8576738 | 0.83 | CA2 (0.44) | CA2CA1TSHRCYP3A4ATM | |
| SCHEMBL8646938 | 0.83 | CA2 (0.44) | CA2CA1TSHRCYP3A4ATM | |
| Urethane SCHEMBL28335653 | 0.82 | ALOX15 (0.58) | CA2CA1ALOX15TSHRCYP3A4 | |
| SCHEMBL28671516 | 0.82 | CA2 (0.42) | CA2CA1TSHRCYP3A4ATM | |
| SCHEMBL11821362 | 0.82 | ALDH1A1 (0.50) | CA2CA1ALOX15TSHRCYP3A4 | |
| SCHEMBL28647763 | 0.82 | ACE2 (0.46) | CA2CA1TSHRCYP3A4ATM | |
| Urethane SCHEMBL28333246 | 0.81 | ALOX15 (0.56) | CA2CA1ALOX15TSHRCYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1112120-B1 | PROCESS AND CATALYST FOR MAKING DIALKYL CARBONATES | CATALYTIC DISTILLATION TECH (US) | 2004-10-20 | — | — | EP | disclosed |
| WO-2002096851-A1 | PROCESS AND CATALYST FOR MAKING CARBONATES | CATALYTIC DISTILLATION TECHNOLOGIES (US) | 2002-12-05 | — | — | WO | disclosed |
| EP-1112120-A4 | PROCESS AND CATALYST FOR MAKING DIALKYL CARBONATES | CATALYTIC DISTILLATION TECH (US) | 2002-07-03 | — | — | EP | disclosed |
| US-20020082439-A1 | Process and catalyst for making dialkyl carbonates | CATALYTIC DISTILLATION TECHNOLOGIES | 2002-06-27 | — | — | US | disclosed |
| US-6392078-B1 | USING AN ORGANOTIN CATALYST | CATALYTIC DISTILLATION TECHNOLOGIES | 2002-05-21 | — | — | US | disclosed |
| US-RE37337-E1 | DIMETHYL CARBONATE; REACTION OF PRIMARY ALCOHOL, SUCH AS METHANOL, WITH UREA IN PRESENCE OF NOVEL ORGANOTIN CATALYST COMPLEX WITH HIGH BOILING ELECTRON DONOR COMPOUND ACTING AS SOLVENT; CONCURRENT DISTILLATION | CATALYTIC DISTILLATION TECHNOLOGIES | 2001-08-21 | — | — | US | disclosed |
| EP-1112120-A1 | PROCESS AND CATALYST FOR MAKING DIALKYL CARBONATES | Catalytic Distillation Technologies (US) | 2001-07-04 | — | — | EP | disclosed |
| WO-2000012212-A1 | PROCESS AND CATALYST FOR MAKING DIALKYL CARBONATES | CATALYTIC DISTILLATION TECHNOLOGIES (US) | 2000-03-09 | — | — | WO | disclosed |
| US-6010976-A | Catalyst for making dialkyl carbonates | CATALYTIC DISTILLATION TECHNOLOGIES (US) | 2000-01-04 | — | — | US | disclosed |
| US-5902894-A | REACTING UREA AND A PRIMARY ALCOHOL IN A REACTION ZONE WITH AN ORGANOTIN COMPOUND AND A HIGH BOILING ELECTRON DONOR ATOM CONTAINING SOLVENT | CATALYTIC DISTILLATION TECHNOLOGIES (US) | 1999-05-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020082439-A1 | Process and catalyst for making dialkyl carbonates | ODC1, ADH1C, DKC1 | CA2 131/4885CA1 339/4885ALOX15 2684/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.